DCF — MERCYONE DUBUQUE MEDICAL CENTER
Enterprise Value: $-135.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-135.1M
Enterprise Value
$-45.2M
PV of Cash Flows
$-89.9M
PV of Terminal Value
$-144.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $157.3M | $-7.1M | -4.0% | $-13.7M | $-12.5M |
| Year 2 | $162.0M | $-5.7M | -3.0% | $-12.5M | $-10.4M |
| Year 3 | $166.9M | $-4.2M | -2.0% | $-11.2M | $-8.4M |
| Year 4 | $171.9M | $-3.4M | -2.0% | $-10.7M | $-7.3M |
| Year 5 | $177.1M | $-3.1M | -2.0% | $-10.6M | $-6.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-135.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$152.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999997381207105
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5